November 5, 2019, Vol 322, No. 17, Pages 1625-1728
A Professional Standard for Informed Consent for Stem Cell Therapies
Jeremy Sugarman, MD, MPH, MA; Roger A. Barker, MRCP, PhD; R. Alta Charo, JD
JAMA. 2019;322(17):1651-1652. doi:10.1001/jama.2019.11290
This Viewpoint summarizes recommendations from an International Society for Stem Cell Research task force charged with developing professional standards of patient consent for stem cell–based interventions offered outside a clinical trial given the spread of unregulated stem cell clinics offering unproven therapies.